Company facts
- Headquarters
- Singapore
- Most recent report
- 6-K, filed Sep 2, 2026
- Filings on record
- 76 filings
- On EDGAR
- CIK 2004489
- Fiscal year ends
- June
- Filer status
- Emerging growth company
Financials 8 of 30
- 6-K Report a foreign issuer made public elsewhere Sep 2, 2026
- 6-K Report a foreign issuer made public elsewhere Aug 10, 2026
- 6-K Report a foreign issuer made public elsewhere Jul 10, 2026
- 6-K Report a foreign issuer made public elsewhere Jun 26, 2026
- 6-K Report a foreign issuer made public elsewhere Jun 10, 2026
- 6-K Report a foreign issuer made public elsewhere Jun 5, 2026
- 6-K Report a foreign issuer made public elsewhere Mar 30, 2026
- 6-K Report a foreign issuer made public elsewhere Mar 24, 2026
Prospectuses and Registrations 5
Ownership 8 of 9
- 3 Insider reported their initial holding Jul 22, 2026
- 3 Insider reported their initial holding Apr 21, 2026
- 3 Insider reported their initial holding Apr 15, 2026
- 3 Insider reported their initial holding Apr 14, 2026
- 3 Insider reported their initial holding Apr 14, 2026
- 3 Insider reported their initial holding Apr 14, 2026
- 3 Insider reported their initial holding Apr 14, 2026
- 3 Insider reported their initial holding Mar 4, 2026
Other 8 of 32
- F-1/A Registration statement, foreign issuer, amended Sep 23, 2026
- DRS Draft registration statement, submitted confidentially Jul 31, 2026
- 20-F/A Annual report, foreign issuer, amended Mar 13, 2026
- NT 20-F Oct 27, 2025
- CERT Exchange certified a listing Feb 21, 2025
- EFFECT Notice that a registration became effective Feb 18, 2025
- 8-A12B Registration of a security for exchange listing Feb 14, 2025
- CORRESP Reply to SEC staff Feb 14, 2025
Everything here comes from Basel Medical Group Ltd's own filings on SEC EDGAR. The filing list is rechecked every hour.